Publications

Publications 2016

December 31, 2016
  1. Phuphanich M, Rattanamahattana M, Avihingsanon A, Chetchotisakd P, Putcharoen O, Gandhi M, Sohn AH, Imrie J, Phanuphak P, Kerr SJ. A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients. J Virus Erad. 2016 Jan 1;2(1):22-7.
  2. Parsons MS, Madhavi V, Ana-Sosa-Batiz F, Center RJ, Wilson KM, Bunupuradah T, Ruxrungtham K, Kent SJ. Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission. J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):17-23. doi: 10.1097/QAI.0000000000000804.
  3. Gupta SK, McComsey GA, Lombaard J, Echevarría J, Orrell C, Avihingsanon A, Osiyemi O, Santoscoy M, Ray N, Stock DA, Joshi SR, Hanna GJ, Lataillade M. Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial. Lancet HIV. 2016 Jan;3(1):e13-22. doi: 10.1016/S2352-3018(15)00231-3. Epub 2015 Dec 12.
  4. Cooper DA, Cordery DV, Zajdenverg R, Ruxrungtham K, Arastéh K, Bergmann F, Neto JL, Scherer J, Chaves RL, Robinson P; study team. Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial. PLoS One. 2016 Jan 5;11(1):e0144917. doi: 10.1371/journal.pone.0144917. eCollection 2016.
  5. Bunpuradah T, Kariminia A, Aurpibul L, Chokephaibulkit K, Hansudewechakul R, Lumbiganon P, Vonthanak S, Vibol U, Saghayam S, Nallusamy R, Nguyen LV, Yusoff NKN, Sohn AH,  Puthanakit T on behalf of the TREAT Asia Pediatric HIV Observational Database. Final height and associated factors in perinatally HIV-infected Asian adolescents. Pediatr Infect Dis J. 2016 Feb;35(2):201-4. doi: 10.1097/INF.0000000000000961.
  6. Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R,Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival. PLoS One. 2016 Mar 2;11(3):e0150512. doi: 10.1371/journal.pone.0150512. eCollection 2016.
  7. Jeong SJ, Italiano C, Chaiwarith R, Ng OT, Vanar S, Jiamsakul A, Saphonn V, Nguyen KV, Kiertiburanakul S, Lee MP, Merati TP, Pham TT, Yunihastuti E, Ditangco R, Kumarasamy N, Zhang F, Wong W, Sim BL, Pujari S, Kantipong P, Phanuphak P, Ratanasuwan W, Oka S, Mustafa M, Durier N, Choi JY. Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD. AIDS Res Hum Retroviruses. 2016 Mar;32(3):255-61. doi: 10.1089/AID.2015.0058. Epub 2015 Oct 15.
  8. Ohata PJ, Avihingsanon A , Ubolyam S, Putcharoen  O, Kerr SJ , Volnysanne A,  Nanthapisal K, Ruengpayyathip C, Bunupuradah T, Prasitsuebsai W, Kukanok S, Do T,  Landolt NK, Ruxrungtham K, Phanuphak P  on behalf of the Symposium Team. Updates on HIV treatment and prevention from Asia’s HIV Symposium. Future Virology. 2016 Mar. DOI: 10.2217/fvl-2016-0017.
  9. Kancheva Landolt N, Bunupuradah T, Chaithongwongwatthana S. Contraceptive challenges in adolescents living with or at risk of HIV. J Virus Erad. 2016 Apr 1;2(2):82-6.
  10. Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Ananworanich J, Puthanakit T; Bone-D Study Group. Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents. AIDS. 2016 Apr 24;30(7):1059-67. doi: 10.1097/QAD.0000000000001032.
  11. Boettiger DC, Sudjaritruk T, Nallusamy R, Lumbiganon P, Rungmaitree S, Hansudewechakul R, Kumarasamy N, Bunupuradah T, Saphonn V, Truong KH, Yusoff NK, Do VC, Nguyen LV, Razali KA, Fong SM, Kurniati N, Kariminia A. Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia. J Adolesc Health. 2016 Apr;58(4):451-459. doi: 10.1016/j.jadohealth.2015.11.006. Epub 2016 Jan 20.
  12. Teeranaipong P, Sirivichayakul S, Mekprasan S, Ohata PJ, Avihingsanon A, Ruxrungtham K, Putcharoen O. Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross- Sectional Study. PLoS One. 2016 Apr 27;11(4):e0154221. doi: 10.1371/journal.pone.0154221. eCollection 2016.
  13. Pozniak A, Arribas JR, Gathe J, Gupta SK, Post FA, Bloch M, Avihingsanon A, Crofoot G, Benson P, Lichtenstein K, Ramgopal M, Chetchotisakd P, Custodio JM, Abram ME, Wei X, Cheng A, McCallister S, SenGupta D, Fordyce MW; GS-US-292-0112 Study Team. Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):530-7. doi: 10.1097/QAI.0000000000000908.
  14. Avihingsanon A, Kerr S, Ramautarsing RA, Praditpornsilpa K, Wongsabut J, Ubolyam S, Avihingsanon Y, Khovidhunkit W, Hiransuthikul NH, Ruxrungtham K. The association of gender, age, efavirenz use and hypovitaminosis D among HIV-infected adults living in the tropics AIDS Research and Human Retroviruses. AIDS Res Hum Retroviruses. 2016 Apr;32(4):317-24. doi: 10.1089/AID.2015.0069. Epub 2015 Oct 15.
  15. Boettiger DC, Aurpibul L, Hudaya DM, Fong SM, Lumbiganon P, Saphonn V, Truong KH, Hansudewechakul R, Nguyen LV, Do VC, Bunupuradah T, Chokephaibulkit K, Nik Yusoff NK, Kumarasamy N, Wati DK, Razali KA, Kariminia A; TREAT Asia Pediatric HIV Observational Database. Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia. Pediatr Infect Dis J. 2016 May;35(5):e144-51. doi: 10.1097/INF.0000000000001074.
  16. Jiamsakul A, Kerr SJ, Ng OT, Lee MP, Chaiwarith R, Yunihastuti E, Van Nguyen K, Pham TT, Kiertiburanakul S, Ditangco R, Saphonn V, Sim BL, Merati TP, Wong W, Kantipong P, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Oka S, Mustafa M, Ratanasuwan W, Petersen B, Law M, Kumarasamy N; TREAT Asia HIV Observational Database (TAHOD). Effects of unplanned treatment interruptions on HIV treatment failure – results from TAHOD. Trop Med Int Health. 2016 May;21(5):662-74. doi: 10.1111/tmi.12690. Epub 2016 Mar 29.
  17. Audsley J, Bent SJ, Littlejohn M, Avihingsanon A, Matthews G, Bowden S, Bayliss J, Luciani F, Yuen L, Fairley CK, Locarnini S, Lewin SR, Sasadeusz J. Effects of long-term tenofovir-based cART in HIV-HBV co-infection on persistent HBV viremia and the role of HBV quasispecies diversity. AIDS. 2016 Jun 19;30(10):1597-606. doi: 10.1097/QAD.0000000000001080.
  18. Sapsirisavat V, Vongsutilers V, Thammajaruk N, Pussadee K, Riyaten P, Kerr S, Avihingsanon A, Phanuphak P, Ruxrungtham K, PEDA study team. Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study – PEDA Study. PLoS One. 2016 Jun 20;11(6):e0157039. doi: 10.1371/journal.pone.0157039. eCollection 2016.
  19. Dickinson L, Amin J, Else L, Boffito M, Egan D, Owen A, Khoo S, Back D, Orrell C, Clarke A, Losso M, Phanuphak P, Carey D, Cooper DA, Emery S, Puls R. Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study. Clin Pharmacokinet. 2016 Jul;55(7):861-873. doi: 10.1007/s40262-015-0360-5.
  20. Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Sierra Madero J, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Fisher M, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Arnaiz JA, Cooper D, Rockstroh JK, Mallon P, Emery S; Maraviroc Switch (MARCH) Study Group. Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study. Clin Infect Dis. 2016 Jul 1;63(1):122-32. doi: 10.1093/cid/ciw207. Epub 2016 Apr 5.
  21. Crowell TA, Phanuphak N, Pinyakorn S, Kroon E, Fletcher JL, Colby D, Tipsuk S, Karnsomlap P, Laopraynak N, O’connell RJ, Robb ML, Ananworanich J; RV254SEARCH010 Study Group. Virologic failure is uncommon after treatment initiation during acute HIV infection. AIDS. 2016 Jul 31;30(12):1943-50. doi: 10.1097/QAD.0000000000001148.
  22. Ku NS, Jiamsakul A, Ng OT, Yunihastuti E, Cuong do D, Lee MP, Sim BL, Phanuphak P, Wong WW, Kamarulzaman A, Zhang F, Pujari S, Chaiwarith R, Oka S, Mustafa M, Kumarasamy N, Van Nguyen K, Ditangco R, Kiertiburanakul S, Merati TP, Durier N, Choi JY; TREAT Asia HIV Observational Databases (TAHOD). Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy. Medicine (Baltimore). 2016 Aug;95(32):e4570. doi: 10.1097/MD.0000000000004570.
  23. Kancheva Landolt N, Bunupuradah T, Kosalaraksa P, Ubolyam S, Thammajaruk N, Cremers S, Zott R, Kerr S, Ananworanich J; HIV-NAT 176 study. High variability of hormonal levels and no clinically relevant interaction between ethinyl estradiol, desogestrel and lopinavir/ritonavir in a small sample of HIV-positive adolescents. J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):507-12. doi: 10.1097/QAI.0000000000000997.
  24. Bunupuradah T, Kiertiburanaku S, Avihingsanon A, Chetchotisakd P, Techapornroong M, Leerattanapetch N, Kantipong P, Bowonwatanuwnog C, Bangchongkit S, Klinbuayaem V, Mekviwattanawong S, Nimitvilai S, Jirajariyavej S, Prasithsirikul W, Munsakul W, Bhakeecheep S,Chaivooth S, Phanuphak P, Cooper DA, Apornpong T, Kerr SJ, Emery S, Ruxrungtham K, for the LASA Study Group. Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial. Lancet HIV. 2016 Aug;3(8):e343-e350. doi: 10.1016/S2352-3018(16)30010-8. Epub 2016 May 24.
  25. Scherpbier HJ, Terpstra V, Pajkrt D, Puthakanit T, Ananworanich J, Foster C, van den Bergh Weerman M, Deurloo EE, van der Valk M, Kuijpers TW, Koot BG. Noncirrhotic Portal Hypertension in Perinatally HIV-Infected Adolescents Treated with Didanosine-Containing Antiretroviral Regimens in Childhood. Pediatr Infect Dis J. 2016 Aug;35(8):e248-52. doi: 10.1097/INF.0000000000001202.
  26. Tanuma J, Jiamsakul A, Makane A, Avihingsanon A, Ng OT, Kiertiburanakul S, Chaiwarith R, Kumarasamy N, Nguyen KV, Pham TT, Lee MP, Ditangco R, Merati TP, Choi JY, Wong WW, Kamarulzaman A, Yunihastuti E, Sim BL, Ratanasuwan W, Kantipong P, Zhang F, Mustafa M, Saphonn V, Pujari S, Sohn AH; TREAT Asia HIV Observational Databases (TAHOD). Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific. PLoS One. 2016 Aug 25;11(8):e0161562. doi: 10.1371/journal.pone.0161562. eCollection 2016.
  27. Do T, Boettiger D, Law M, Pujari S, Zhang F, Chaiwarith R, Kiertiburanakul S, Lee MP, Ditangco R, Wong W, Hguyen KV, Parwati M, Pham TT, Kamarulzaman A, Oka S, Yunihastuti E, Kumarasamy N, Kantipong P, Choi JY, Ng OT, Durier N, Ruxrungtham R. Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.. HIV Med. 2016 Aug;17(7):542-9. doi: 10.1111/hiv.12358.
  28. Jiamsakul A, Kerr SJ, Chandrasekaran E, Huelgas A, Taecharoenkul S, Teeraananchai S, Wan G, Ly PS, Kiertiburanakul S, Law M; TREAT Asia HIV Observational Database (TAHOD); TREAT Asia HIV Observational Database TAHOD. The occurrence of Simpson’s paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database. J Clin Epidemiol. 2016 Aug;76:183-92. doi: 10.1016/j.jclinepi.2016.01.030. Epub 2016 Feb 4.
  29. Prasitsuebsai W, Teeraananchai S, Singtoroj T, Truong KH, Ananworanich J, Do VC, Nguyen LV, Kosalaraksa P, Kurniati N, Sudjaritruk T, Chokephaibulkit K, Kerr SJ, Sohn AH. Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in Asia. J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):380-6. doi: 10.1097/QAI.0000000000000971.
  30. Squires K, Kityo C, Hodder S, Johnson M, Voronin E, Hagins D, Avihingsanon A, Koenig E, Jiang S, White K, Cheng A, Szwarcberg J, Cao H. Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study. Lancet HIV. 2016 Sep;3(9):e410-e420. doi: 10.1016/S2352-3018(16)30016-9. Epub 2016 May 27.
  31. The BREATHER (PRENTA 16) Trial Group. Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomized, open-label, non-inferiority, phase 2/3 trial. Lancet HIV. 2016 Sep;3(9):e421-e430. doi: 10.1016/S2352-3018(16)30054-6. Epub 2016 Jun 20.
  32. Maughan RT, Feeney ER, Capel E, Capeau J, Domingo P, Giralt M, Lange JM, Phanuphak P, Cooper DA, Reiss P, Mallon PW; HIVNAT-019 Study Group. Improved adipose tissue function with initiation of protease inhibitor-only ART. J Antimicrob Chemother. 2016 Nov;71(11):3212-3221. Epub 2016 Aug 11.
  33. Sapsirisavat V, Phanuphak N, Sophonphan I, Egan JE, Langevattana K, Avihingsanon A, Friedman MR, Stall, R, and the FAITH study team. Differences Between Men Who Have Sex with Men (MSM) with Low CD4 Cell Counts at Their First HIV Test and MSM with Higher CD4 Counts in Bangkok, Thailand. AIDS Behav. 2016 Dec;20(Suppl 3):398-407.
  34. Punyawudho B, Singkham N, Thammajaruk N, Dalodom T, Kerr SJ, Burger DM, Ruxrungtham K. Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients. Expert Rev Clin Pharmacol. 2016 Dec;9(12):1583-1595. Epub 2016 Sep 23.
  35. Aurpibul L, Teerananchai S, Prasitsuebsai W, Sudjaritruk T, Kosalaraksa P, Kurniati N, Truong KH, Do VC, Van Nguyen L, Chokephaibulkit K, Singtoroj T, Kerr SJ; TASER-Pediatrics Study Group. Therapeutic Drug Monitoring of Lopinavir in HIV-infected Children on Second-line Antiretroviral Therapy in Asia. Ther Drug Monit. 2016 Dec;38(6):791-795.
  36. Boettiger DC, Kerr S, Ditangco R, Chaiwarith R, Li PC, Merati TP, Pham TT, Kiertiburanakul S, Kumarasamy N, Vonthanak S, Lee CK, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Law M. on behalf of the TREAT Asia Observational Database. Tenofovir-based Antiretroviral Therapy in Hepatitis B Virus/HIV Co-infection: Results from the TREAT Asia HIV Observational Database. ntivir Ther. 2016;21(1):27-35. doi: 10.3851/IMP2972. Epub 2015 Jun 12.
  37. Ananworanich J, Sacdalan CP, Pinyakorn S, Chomont N, de Souza M, Luekasemsuk T, Schuetz A, Krebs SJ, Dewar R, Jagodzinski L, Ubolyam S, Trichavaroj R, Tovanabutra S, Spudich S, Valcour V, Sereti I, Michael N, Robb M, Phanuphak P, Kim JH, Phanuphak N. Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection. J Virus Erad. 2016;2:43-48.